A look at Teladoc’s primary care strategy from its head of US group health
In an interview, Kelly Bliss teased upcoming clients for a new virtual-first primary care product and parsed out Teladoc’s growth strategies for 2022 and beyond.
In an interview, Kelly Bliss teased upcoming clients for a new virtual-first primary care product and parsed out Teladoc’s growth strategies for 2022 and beyond.
Prior authorization requirements were the most frequently cited hurdle, while requirements for Medicare’s Quality Payment Program and COVID-19 workplace mandates tied for second, a survey by the medical practices group found.
The expert panel pressed Pfizer and the FDA on the shot’s safety, but ultimately were convinced by the potential for significant benefit in 5- to 11-year-olds.
The deal announced earlier this year would have left LifePoint with some 200 acute, long-term and rehab hospitals, but the private-equity backed companies are electing to spin a number of facilities off into a separate business.
“I’m not sure we’re yet in a place where we would say that things are stable,” GE CEO Larry Culp told investors Tuesday. The healthcare unit took the biggest hit among the conglomerate’s business lines due to delays.
The virtual-first plans will initially be available to large, self-insured employers, though the insurer is looking to expand to smaller sized and fully insured clients over time.
The chain posted higher acute care revenues that helped offset lower volumes at its behavioral health facilities during the third quarter, though labor shortages remain a key challenge.
The insurer rebounded in the third quarter as patient utilization returned to more normal levels and revenue increased 11% year over year.
Emsana is the latest independent venture from employer interests looking to disrupt the healthcare industry, something easier said than done.
The outcome of a high-stakes advisory panel Tuesday could open the door for millions of kids to receive Pfizer’s coronavirus vaccine. Here’s what we know.